Prospective observational study on prediction of impaired glucose tolerance after initiation of glucocorticoid therapy for non-diabetic patients
Not Applicable
Recruiting
- Conditions
- diabetes mellitus
- Registration Number
- JPRN-UMIN000029225
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Case of diabetes type at 75 g OGTT before glucocorticoid therapy. 2. Patients with severe renal dysfunction (serum Cre value before treatment start is greater than 1.5 mg / dl). 3. Cases with severe liver dysfunction (having decompensated cirrhosis or AST / ALT before treatment start more than 3 times higher than normal upper limit). 4. Cases with moderate inflammatory findings (CRP > 1.0 mg / dl or body temperature > 38.0). 5. Patients with gastrointestinal surgery history. 6. Case of using a calcineurin inhibitor. 7. Cases with malignant tumors and being treated. 8. Pregnancy, brestfeeding cases. 9. Other cases that the researcher deemed inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of onset of glucocorticoid-induced hyperglycemia 28 days after glucocorticoid therapy
- Secondary Outcome Measures
Name Time Method